Hims & Hers Health shares plunge 14% - here's what is fueling the fall

Hims stock: Shares of telehealth company Hims & Hers Health tumbled nearly 13% on Friday after investors reacted to news that CEO Andrew Dudum had sold a significant portion of his stake, worth roughly $11 million, as per a report.

Hims Stock Drops After CEO’s $11 Million Stock Sale

According to a US Securities and Exchange Commission (SEC) filing released Thursday, Dudum sold 175,661 shares of the company, as per a Seeking Alpha report. The transaction was carried out under Rule 144, which governs the sale of restricted and controlled securities, and appears to have been made under a prearranged investment plan, as per the report.

Andrew Dudum’s Recent Stock Activity Raises Eyebrows

The filing also showed that about 125,000 of the shares came from options, while the rest were tied to restricted stock vesting, as reported by Seeking Alpha. In addition, between mid-July and mid-September, Dudum or one of his trusts offloaded roughly $29.3 million worth of shares, as per the report.


ALSO READ: Struggling with credit card bills during the government shutdown? Here's a lifeline you can use

Hims & Hers Launches Menopause and Perimenopause Health Service

The timing of the latest sale drew attention as it came just one day after Hims & Hers announced a major new service aimed at women experiencing menopause and perimenopause, as per a Stocktwits report. The new offering provides personalized treatment plans through the company’s digital platform, targeting symptoms such as hot flashes, mood swings, and sleep issues, according to the Stocktwits report.

Retail Investors Remain Cautiously Bullish on Hims & Hers Stock

Despite the successful launch, Friday’s trading session saw heavy selling pressure, with HIMS stock ranking among the most discussed tickers on Stocktwits, as per the report. Retail investors kept chatter levels “extremely high,” though sentiment remained cautiously bullish despite the steep drop, as per the Stocktwits report.

The sell-off highlights investor sensitivity around insider share sales, even when they are part of predetermined trading plans. While Hims & Hers continues to expand its health service offerings, the market’s reaction underscores how leadership stock moves can quickly shake confidence, at least in the short term.

ALSO READ:Signs of disaster: Americans drown in record $1.33 trillion credit card debt, and it’s still climbing

FAQs

Why did Hims stock fall today?

The stock dropped after news broke that CEO Andrew Dudum sold about $11 million worth of shares.

How many shares did Andrew Dudum sell?

He sold 175,661 shares of Hims & Hers Health, as per an SEC filing.